OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Electric Shock Sensation reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,654 reports · 86 co-occurring drugs

As of the last recalculation, Electric Shock Sensation appears in 2,654 FAERS reports alongside 86 co-occurring drug terms. The strongest observed disproportionality signal is ADO-TRASTUZUMAB EMTANSINE (PRR 25.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Ado-Trastuzumab Emtansine2725.425.4
Venlafaxine20324.024.1
Vilazodone Hydrochloride2521.421.5
Ofatumumab8219.920.0
Duloxetine15818.818.9
Desvenlafaxine Succinate5716.916.9
Venlafaxine Hydrochloride25116.316.4
Siponimod1715.015.1
Eptinezumab-Jjmr1714.714.8
Escitslopram8912.412.4
Escitalopram Oxalate11012.312.3
Human Immunoglobulin G3212.312.3
Tramadol Hydrochloride5712.112.1
Diroximel Fumarate1811.911.9
Duloxetine Hydrochloride23210.510.5
Sertraline1288.98.9
Fremanezumab-Vfrm138.98.9
Heparin Sodium158.68.6
Escitalopram1458.58.5
Ocrelizumab658.48.4
Magnesium858.38.4
Paroxetine Hydrochloride Hemihydrate358.38.3
Methylprednisolone Sodium Succinate488.28.2
Paroxetine358.28.2
Mirtazapine928.18.1
Pertuzumab277.97.9
Nitrofurantoin167.67.7
Felodipine Extended-Release Tablets117.67.6
Felodipine117.67.6
Nitrofurantoin (Monohydrate/Macrocrystals)167.57.6
Rimegepant Sulfate127.57.5
Trimethoprim117.37.4
Teriflunomide417.27.2
Fluoxetine607.27.2
Hydroxyzine Hydrochloride116.66.6
Hydroxyzine Hydrochloride Oral116.66.6
Hydroxyzine396.56.5
Calcium, Magnesium, Potassium, And Sodium Oxybates76.46.4
Oxcarbazepine266.36.3
Moxifloxacin Hydrochloride166.26.2
Brimonidine Tartrate146.26.2
Paroxetine Hydrochloride706.26.2
Moxifloxacin116.16.1
Vortioxetine136.06.0
Lamotirigine515.75.7
Lamotrigine Extended-Release515.75.7
Lamotrigine Chewable Dispersible515.75.7
Abaloparatide215.65.6
Progesterone165.55.5
Fluoxetine Hydrochloride875.55.5
Oxybutynin Chloride65.45.4
Aripiprazole Oral285.45.4
Aripiprazole Orally Disintegrating285.45.4
Lisdexamfetamine Dimesylate225.35.3
Bupropion295.25.2
Naltrexone205.15.1
Botulinum Toxin Type A85.15.1
Cetirizine Hydrochloride Allergy194.95.0
Cetirizine Hydrochloride Tablets194.95.0
Phenytoin134.94.9
Lacosamide224.74.7
Avapritinib74.54.5
Esketamine Hydrochloride104.44.4
Bupivacaine54.24.2
Cladribine54.14.1
Onabotulinumtoxina394.04.0
Guanfacine44.04.0
Rotigotine73.83.8
Trastuzumab303.53.5
Cariprazine43.43.4
Inclisiran32.92.9
Brexpiprazole62.82.8
Peginterferon Beta-1A42.42.4
Etonogestrel142.32.3
Dalfampridine192.12.1
Tafamidis32.02.0
Relugolix62.02.0
Buprenorphine232.02.0
Somatropin181.91.9
Dimethyl Fumarate301.91.9
Valbenazine61.91.9
Tirzepatide371.81.8
Erenumab-Aooe111.61.6
Galcanezumab-Gnlm61.51.5
Pimavanserin Tartrate91.31.3
Nirmatrelvir And Ritonavir71.01.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.